PCSK9 and coronary atherosclerosis: For this and other reasons [36–38], examination of the effects of PCSK9 variants on the risk of subsequent CHD events in patients with established coronary atherosclerosis is the subject of a separate analysis led by the GENIUS-CHD consortium [38].